共 50 条
- [26] Outcomes of Patients Receiving Downstream Revascularization After Initial Medical Management for Non-ST-Segment Elevation Acute Coronary Syndromes (From the TRILOGY ACS Trial) AMERICAN JOURNAL OF CARDIOLOGY, 2018, 122 (08): : 1322 - 1329
- [28] Health-related quality of life outcomes with prasugrel among medically managed non-ST-segment elevation acute coronary syndrome patients: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) trial AMERICAN HEART JOURNAL, 2016, 178 : 55 - 64